Open access · CC-BY
via OpenAlex
Significance of inflammatory biomarkers in clinical diagnostics: Erythrocyte sedimentation rate versus other inflammatory biomarkers: A review
Christopher Aloy Simeon, Godae Fidelis Beega, Chinwendu Doris Wofuru, Chinemerem Cynthia Eze
International Journal of Science and Research Archive · 2024 · ▲ 15 citations
Abstract
Inflammation is the immune system's response to various stimuli such as cellular injury, microbial infections, physical and chemical insults, tissue damage, and autoimmune or hypersensitivity reactions. Biomarkers derived from serum, plasma, or blood proteins provide valuable diagnostic and prognostic information regarding these inflammatory conditions. Inflammatory biomarkers, crucial for assessing the presence, severity, and progression of inflammation, include the erythrocyte sedimentation rate (ESR) which remains a key laboratory measure for disease activity, useful in diagnosing and monitoring diseases like polymyalgia, rheumatoid arthritis, systemic lupus erythematosus (SLE), multiple myeloma, Hodgkin’s disease, septic arthritis, and osteomyelitis, thus, commonly measured in clinical practice. ESR is influenced by factors including technical aspects such as room temperature, time from specimen collection, tube orientation, and use of anticoagulants; lifestyle factors like physical activity; as well as serum protein concentrations, age, and gender, prompting the development of more advanced biomarkers which offer improved sensitivity, specificity, and predictive value. Acute-phase proteins like C-reactive protein, serum amyloid A protein, and cytokines such as interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α), are crucial for understanding disease pathophysiology and improving patient care. Measuring these biomarkers aids in early disease identification, accurate diagnoses, and effective treatments, ultimately enhancing patient outcomes and optimising healthcare spending. While ESR remains widely used, newer biomarkers offer greater sensitivity and specificity, improving decision-making and therapeutic monitoring.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.30574/ijsra.2024.12.2.1469
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Simeon, C.A., Beega, G.F., Wofuru, C.D., & Eze, C.C. (2024). Significance of inflammatory biomarkers in clinical diagnostics: Erythrocyte sedimentation rate versus other inflammatory biomarkers: A review. <em>International Journal of Science and Research Archive</em>. https://doi.org/10.30574/ijsra.2024.12.2.1469
Vancouver
Simeon CA, Beega GF, Wofuru CD, Eze CC. Significance of inflammatory biomarkers in clinical diagnostics: Erythrocyte sedimentation rate versus other inflammatory biomarkers: A review. International Journal of Science and Research Archive. 2024. doi:10.30574/ijsra.2024.12.2.1469.
BibTeX
@article{christopher2024Signif,
title = {Significance of inflammatory biomarkers in clinical diagnostics: Erythrocyte sedimentation rate versus other inflammatory biomarkers: A review},
author = {Christopher Aloy Simeon and Godae Fidelis Beega and Chinwendu Doris Wofuru and Chinemerem Cynthia Eze},
journal = {International Journal of Science and Research Archive},
year = {2024},
doi = {10.30574/ijsra.2024.12.2.1469},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European Heart Journal 2023
Open access · OA
Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction
Kardiologiia 2024
Open access · CC-BY
Inflammatory Biomarkers in Patients With Type 2 Diabetes Mellitus and Heart Failure With Preserved Ejection Faction
Biomolecules 2021
Open access · CC-BY
Confounders in Identification and Analysis of Inflammatory Biomarkers in Cardiovascular Diseases
Molecular Neurodegeneration 2015
Open access · CC-BY
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
Frontiers in Pediatrics 2021
Open access · CC-BY
Biomarkers in COVID-19: An Up-To-Date Review
2022
Open access · OA